The WAVE3/β-Catenin Oncogenic Signaling Regulates Chemoresistance in Triple Negative Breast Cancer

The Cancer Genome Atlas dataset was used to assess the expression of WAVE3 and β-catenin in breast cancer tumors. Kaplan–Meier Plotter analysis was used to correlate expression of WAVE3 and β-catenin with breast cancer patients’ survival probability.